Next-gen SNPXplex Formulations

About Bio-Xtal

BioXtal is a long-established, private French CRO that has evolved from providing general R&D services to developing a proprietary technology platform. Its core business remains fee-for-service work in protein sciences and structural biology. The company's strategic shift is marked by the 2024 creation of a spin-off to focus on commercializing its SNPXplex® reagent, a product for NGS sample identity tracking, signaling a move into the diagnostics and personalized medicine tools market. This positions BioXtal as a hybrid service-provider and product-developer.